लोड हो रहा है...
Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
PURPOSE: To discuss new therapeutic strategies for chemotherapy-induced nausea and vomiting (CINV) involving 5-hydroxytryptamine type 3 (5HT(3))-receptor antagonists (RAs). SUMMARY: CINV remains poorly controlled in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic che...
में बचाया:
| में प्रकाशित: | Cancer Manag Res |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove Medical Press
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037149/ https://ncbi.nlm.nih.gov/pubmed/30013391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S166912 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|